BioSpace News Archive

Press Releases

Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma

October 29, 2024
·
4 min read
Press Releases

TREMFYA® (guselkumab) is the first and only IL-23 inhibitor to demonstrate robust results with a fully subcutaneous regimen in both induction and maintenance in Crohn’s disease

October 29, 2024
·
15 min read
Press Releases

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update

October 29, 2024
·
7 min read
Press Releases

Impella ECP Pivotal Study Demonstrates Safety, Efficacy for Use in High-Risk PCI

October 29, 2024
·
4 min read
Press Releases

Positive Preliminary Results Demonstrate Autonomix’s Proprietary RF Ablation Technology’s Ability to Reduce Opioid Use in Ongoing Human Clinical Trial

October 29, 2024
·
8 min read
Press Releases

Ainos Expands Patent Portfolio With Strategic Shareholder’s Cutting-Edge Technology Assets

October 29, 2024
·
7 min read
Press Releases

The START Center for Cancer Research and Fundación Rioja Salud Announce New Partnership to Further Expand Access to Early Phase Clinical Trials in Spain

October 29, 2024
·
3 min read
Press Releases

Chiesi Global Rare Diseases Announces Publication of Results from Phase 3 BRIGHT Study of ELFABRIO® (pegunigalsidase alfa-iwxj) in Fabry Disease

October 29, 2024
·
7 min read
Press Releases

Inari Medical Reports Third Quarter 2024 Financial Results

October 29, 2024
·
12 min read
Press Releases

Texas Biomedical Research Institute enters landmark partnership with Coalition for Epidemic Preparedness Innovations

October 29, 2024
·
3 min read